The funds will be used to scale its remote monitoring platform.
The NHS app will be used to demonstrate COVID-19 vaccination status
The partnership will work on a drug discovery programme for the genetic muscle wasting disorder.
A white paper from Research2Guidance finds that gaining DiGA approval alone does not ensure the adoption and success of healthcare apps.
The investment will be used to fund further European expansion.
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
The funds will be used to develop the firm’s non-invasive blood sensing technology.
The sterilisation method has been used in hospitals and laboratories for more than 50 years.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Concerns raised that EU Health Technology Assessment Regulation could lead to delays in market approval.